Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome

dc.contributor.author
Cruz Martínez, Ofelia
dc.contributor.author
Caloretti, Victoria
dc.contributor.author
Salvador, Héctor
dc.contributor.author
Celis, Verónica
dc.contributor.author
Santa-Maria Lopez, Vicente
dc.contributor.author
Morales La Madrid, Andrés
dc.contributor.author
Suñol, Mariona
dc.contributor.author
Puerta, Patricia
dc.contributor.author
Muchart López, Jordi
dc.contributor.author
Krauel, Lucas
dc.contributor.author
Lavarino, Cinzia
dc.date.issued
2021-03-18T11:06:37Z
dc.date.issued
2021-03-18T11:06:37Z
dc.date.issued
2021-01-06
dc.date.issued
2021-03-18T11:06:37Z
dc.identifier
1731-2302
dc.identifier
https://hdl.handle.net/2445/175298
dc.identifier
706106
dc.identifier
33407742
dc.description.abstract
Background: Li-Fraumeni Syndrome (LFS) is a cancer predisposition syndrome characterized by the early-onset of multiple primary cancers which can occur at different moments (metachronous onset) or, more rarely, coincidentally (synchronous onset). Here we describe a previously unreported patient with presentation of synchronous Wilms tumor and Choroid plexus papilloma, leading to the diagnosis of a Li-Fraumeni Syndrome (LFS). Case presentation: A 6-year-old girl without previous complains presented with abdominal pain. Abdominal US and MRI showed a left renal tumor with subcapsular hematoma. Due to mild headaches, the diagnostic workup included a brain MRI that unexpectedly identified a large left parietal lobe tumor. Histopathological analysis determined the diagnosis of classic Wilms tumor and choroid-plexus papilloma (CPP), respectively. Both neoplasms showed intense nuclear p53 immunostaining associated with the pathogenic TP53 mutation c.844C > T (p.Arg282Trp). Our patient and her father shared the same heterozygous germline TP53 mutation, confirming the diagnosis of familiar Li-Fraumeni syndrome in the girl. The treatment was tailored to simultaneous tumor presentations. Conclusions: LFS has been associated with Choroid plexus carcinoma (CPC), but rarely with CPP as in our patient. That suggests that it may be advisable to consider the possibility of analyzing TP53 mutation, not only in all patients with CPC, but also in some patients with CPP, especially when histological or clinical evidences point out to perform this study. The dissimilar presentation of LFS among our patient's father, not having so far any neoplasia diagnosed, while her daughter presented precociously with two simultaneous different tumors, could be related to possible effects of modifier genes on the underlying mutant p53 genotype.
dc.format
6 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
BioMed Central
dc.relation
Reproducció del document publicat a: https://doi.org/10.1186/s13053-020-00158-7
dc.relation
Hereditary Cancer in Clinical Practice , 2021, vol. 19, num. 1
dc.relation
https://doi.org/10.1186/s13053-020-00158-7
dc.rights
cc-by (c) Cruz Martínez, Ofelia et al., 2021
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
dc.subject
Tumors
dc.subject
Papil·lomavirus
dc.subject
Histopatologia
dc.subject
Tumors
dc.subject
Papillomaviruses
dc.subject
Pathological histology
dc.title
Synchronous choroid plexus papilloma and Wilms tumor in a girl, disclosing a Li-Fraumeni syndrome
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)